Soratib 200mg Tablet
In stock
Description
Soratib 200 mg (containing Sorafenib) is an oral tyrosine kinase inhibitor (TKI) used to treat advanced kidney (renal cell carcinoma), liver (hepatocellular carcinoma), and thyroid cancers. It works by inhibiting multiple receptors to block angiogenesis (blood vessel formation) and tumor cell proliferation.
Specifications
| Strength | 200mg |
|---|---|
| Main Ingredients | Sorafenib |
| Pack Size | 120 Tablets |
| Dosage Form | Tablet (Film-coated) |
| Uses | Liver cancer, Kidney cancer, and Thyroid cancer. |
| Storage | Store below 30°C |
